Stocktoria

CUMBERLAND PHARMACEUTICALS INC CPIX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2009-08-11

CUMBERLAND PHARMACEUTICALS INC statistics & valuation

Market cap$101.1M
P / S2.3×
P / B4.1×
P / FCF20.9×
Net margin-6.4%
Return on equity-11.4%
FCF margin10.9%
Return on capital-7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-2.90% -19.40% -23.70% -10.30% -8.90% -9.70% -13.30% -15.90% -17.10% -6.40% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-4.30% -9.90% -38.10% -27.00% -17.00% -21.30% -13.60% -24.20% -17.00% -6.30% 2016201720182019202020212022202320242025
Return on equity (%)
-1.30% -12.40% -12.50% -6.90% -7.10% -8.20% -15.40% -21.20% -28.40% -11.40% 2016201720182019202020212022202320242025
Shares outstanding
16.2M 16.1M 15.6M 15.4M 15.2M 14.9M 14.6M 14.3M 14.1M 15.0M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-1.00% -8.60% -6.20% -3.40% -3.50% -4.20% -6.00% -7.70% -8.60% -3.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
1.30% -2.00% 9.10% 8.20% 14.10% 17.30% 19.90% 14.70% -1.80% 10.90% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.06 -$0.50 -$0.45 -$0.23 -$0.22 -$0.24 -$0.38 -$0.44 -$0.46 -$0.19 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

CUMBERLAND PHARMACEUTICALS INC trades at about 197.7× earnings — above its 10-year norm (10-year range 14×–124×, median 41.5×).

14× 197.7×

Shaded band = 10-year range (14×–124×); dot = today's 197.7×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-6.3%-17.0%-24.2%-13.6%-21.3%-17.0%-27.0%-38.1%-9.9%-4.3%
Net margin-6.4%-17.1%-15.9%-13.3%-9.7%-8.9%-10.3%-23.7%-19.4%-2.9%
FCF margin10.9%-1.8%14.7%19.9%17.3%14.1%8.2%9.1%-2.0%1.3%
Return on assets-3.7%-8.6%-7.7%-6.0%-4.2%-3.5%-3.4%-6.2%-8.6%-1.0%
Return on equity-11.4%-28.4%-21.2%-15.4%-8.2%-7.1%-6.9%-12.5%-12.4%-1.3%
Current ratio1.011.151.281.602.371.952.082.133.884.43

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.